The D.C. area saw its biggest first quarter in startup funding in at least 16 years, with companies raking in more than $473.3 million in venture capital with the biotech and software sectors leading the way, according to data provided by PitchBook.
{iframe}https://www.bizjournals.com/washington/news/2018/04/10/medimmune-spinoff-leads-greater-washington-to.html{/iframe}